Trial Profile
Phase 2 study of MDNA55 in patients with metastatic brain cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2017
Price :
$35
*
At a glance
- Drugs Bizaxofusp (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- 23 Jun 2017 New trial record
- 16 Jun 2017 According to a Medicenna Therapeutics media release, company plans to begin enrolling patients for this trial in the second half of 2017.